Language selection

Search

Patent 1112178 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1112178
(21) Application Number: 1112178
(54) English Title: QUINONIC OR PHENOLIC COMPOUNDS AS TOPICAL COMPOSITIONS
(54) French Title: COMPOSES QUINONIQUES OU PHENOLIQUES A USAGE LOCAL
Status: Term Expired - Post Grant
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 31/47 (2006.01)
  • A61K 31/122 (2006.01)
  • A61K 31/305 (2006.01)
  • A61P 17/14 (2006.01)
  • A61Q 7/00 (2006.01)
(72) Inventors :
  • MARECHAL, RAYMOND (Belgium)
(73) Owners :
  • MARECHAL, RAYMOND
(71) Applicants :
  • MARECHAL, RAYMOND
(74) Agent: SWABEY OGILVY RENAULT
(74) Associate agent:
(45) Issued: 1981-11-10
(22) Filed Date: 1978-07-28
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract


ABSTRACT OF THE DISCLOSURE
The invention is concerned with a topical composition
for use on the scalp in seborrheic alopecia, dandruff, greasy
hairs and male pattern baldness. The composition of the inven-
tion contains as active ingredient at least one aromatic com-
pound selected from the group consisting of o-benzoquinone,
p-benzoquinine, menadione, menadione sodium bisulfite, potassium
o-oxyquinolinsulfate and sodium merthiolate, together with a
liquid carrier.


Claims

Note: Claims are shown in the official language in which they were submitted.


The embodiments of the invention in which an exclusive
property or privilege is claimed are defined as follows:
1. A topical composition for use on the scalp in
seborrheic alopecia, dandruff, greasy hairs and male pattern
baldness, said composition containing as active ingredient at
least one aromatic compound selected from the group consisting
of o-benzoquinone, p-benzoquinone, menadione, menadione
sodium bisulfite, potassium o-oxyquinolinsulfate and
sodium merthiolate,together with a liquid carrier.
2. A topical composition according to claim 1,
containing about 0.2% by weight of potassium o-oxyquinolin-
sulfate as active ingredient.
3. A topical composition according to claim 1,
containing about 0.6% by weight of sodium merthiolate as
active ingredient.
4. A topical composition according to claim 1,
containing about 1% to 2.5% by weight of menadione sodium
bisulfite as active ingredient.
5. A topical composition according to claim 1, in
which the liquid carrier is water and/or a lower alcohol.

Description

Note: Descriptions are shown in the official language in which they were submitted.


~ 7 8
TOPICAL COr~OSITION FO~ USE ON THE SCALP
This invention relates to new topical composi-
tions for use on the scalp in seborrheic alopecia, dandruff,
greasy hairs and male pattern baldness.
Until now the purpose of the general and local
treatments of said conditions was mainly to maintain an
abundant blood circulation in the scalp, so as to gi~e the
hair follicles and sebaceous glands as much food as possible.
On the other hand, it is well kno~n that the
androgens are responsible for the accelaration of the cell
metabolism at the level of the follicles and sebaceous glands,
so that the more the blood circulation is abundant, the more
toxic androgens are supplied per time unit.
It is therefore necessary to try a local re-
duction of the action of the androgens.
Applicant has obtained such a reduction by
modifying the blood circulation at the scalp level by
bilateral ligatures of the superficial temporal arteries,
of the back auricular arteries and o~ the occipital arteries.
Such an artery cut or strung causes a noticeable decrease
of the blood flow and an important hypoxia in the skin
territory of the seborrheic alopecia. This therapeutical
action causes an inhibition of enzymes, such as 5 - alpha-
reductase which converts the flowing testosterone into di-
hydrotestosterone which is a metabolite acting on the hair
follicles and the sebaceous glands.
It has also been proposed to inhibit the
action of the scalp by using locally steroids, such as
deoxycorticosterone, androstenedione and progesterone.
However, said steroids are not suitable.

B
Deoxycorticosterone acts on the mineral metabolism
and can therefore not be used as a useful antiandrogen.
Androstenedione is converted into testosterone in the tissues
and does therefore not any more as antiandrogen. Finally
progesterone is a precursor of the androgenic steroids.
Applicant has found products which inhibit the scalp
enzymes, without having the drawbacks of the above steroids.
In accordance with the invention, there is thus
provided a topical composition for use on the scalp in
10 seborrheic alopecia, dandruff, greasy hairs and male pattern
baldness, which contains as active ingredient at least one
aromatic compound selected from the group consisting of o-
benzoquinone, p-benzoquinone, menadione, menadione sodium
bisulfite, potassium o-oxyquinolinsulfate and sodium merthio-
late, together with a liquid carrier.
The active ingredient may be dissolved or dispersed
in the liquid carrier. The liquid carrier may comprise water
or a lower alcohol, such as methanol or ethanol, or a mixture
thereof.
The active ingredients may modify the electron
transport in several ways to inhibit some enzymatic systems
of the skin or scalp.
Some mercury salts generally known as most potent
inhibitors of the SH reagent groups of the enzymes have been
investigated. One of the more powerful of them and the most
innocuous seems to be sodium merthiolate.
Under these conditions, Applicant has treated 296
cases of male seborrheic alopecia with different topical
solutions as described hereafter. Active ingredients were
mostly diluted in water, rarely in alcohol.
--2--
,
.,

17B
249 patients suffering from dandruff, greasy hair
and hair shedding have been treated. I noticed in the other
patients only greasy hair and loss of hair.
All the patients were topically treated five times
a week.
b) Among 15 cases treated with menadione Na bisulfite
(2.5%) I noticed 86% improvement, dandruff and hair shedding
were becoming better than seborrhea.
c) Among 56 patientsj 89% were improved, using ~a
merthiolate (2/oo): hair shedding, dandruff as well as
seborrhea.
d) Among 58 patients treated with K-o-Oxyquinolin-
sulfate (6/oo ), 84% showed improvement in the three principal
symptoms.
e) Among 27 patients using catechol (1/oo ), 80~ were
improved, better hair shedding and dandruff than seborrhea.
; f) Among 69 patients using a blended aqueous lotion
including one part by weight of menadione ~a bisulfite (1%), one
part by weight of catechol (1 /oo), one part by weight of hydro-
20 quinone ~2%) and one part by weight of K-o-Oxyquinolinsulfate
(6 /OO)~ 87% improvement was noticed as well in dandruff and
; hair shedding as greasy hairs.
g) Among 26 patients using Na merthiolate (2 /OO)
and K-o-Oxyquinolinsulfate (6 /OO) mixed fifty-fifty, 95%
were totally improved.

Representative Drawing

Sorry, the representative drawing for patent document number 1112178 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC deactivated 2013-11-12
Inactive: IPC assigned 2013-08-01
Inactive: IPC assigned 2013-08-01
Inactive: IPC assigned 2013-08-01
Inactive: IPC assigned 2013-08-01
Inactive: First IPC assigned 2013-08-01
Inactive: IPC assigned 2013-08-01
Inactive: Expired (old Act Patent) latest possible expiry date 1998-11-10
Grant by Issuance 1981-11-10

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
MARECHAL, RAYMOND
Past Owners on Record
RAYMOND MARECHAL
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 1994-03-23 1 9
Drawings 1994-03-23 1 5
Abstract 1994-03-23 1 14
Claims 1994-03-23 1 25
Descriptions 1994-03-23 3 104